VA-OraLube

saliva substitute for treatment of xerostomia (dry mouth); provides protection to soft tissues & promotes enamel remineralization; contains K phosphates, K, Na, Mg & Ca chlorides, NaF, sorbitol, flavoring, dye, preservative, water with added carboxymethylcellulose; Xero-Lube reported to have same formulation; RN given refers to VA-OraLube with unknown MF

Also Known As:

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Xerostomia 12/01/1978 - "The inclusion of 2.0 ppm F in OraLube assures that, in addition to its ability to relieve intraoral soft tissue problems associated with xerostomia, an optimal rehardening potential is provided."
2.	Neoplasms (Cancer) 05/01/1978 - "A saliva substitute, VA-OraLube, was evaluated for ability to reharden dental enamel and to relieve intraoral soft tissue symptoms in patients receiving radiotherapy for malignancies of the head and neck. "

Related Therapies and Procedures

1.	Radiotherapy